Biondvax Pharmaceuticals Ltd. ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.05 |
Market Cap |
$38.04 M |
Shares Outstanding |
6.54 M |
Public Float |
6.18 M |
Address |
Jerusalem BioPark Jerusalem JM 74036 Israel |
Employees | - |
Website | http://www.biondvax.com |
Updated | 07/08/2019 |
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Ness Ziona, Israel. |